Hemispherx signs with GP Pharm to manufacture Ampligen in Argentina
Hemispherx Biopharma announced a preliminary stage agreement with GP Pharm to manufacture Ampligen in Argentina in order to serve Latin American markets pending approval.
Archives for May 22, 2014
Merck to invest $68m in Italian biopharma production site
As part of an effort to meet a rising demand for biopharmaceuticals, Germany-based Merck has agreed to invest about $68m (€50m) in its Italian production site in Bari.
Pfizer nabs Roslin Cells in cell therapy manufacturing deal
Roslin Cells has signed a contract with Neusentis, a research unit of Pfizer based in Cambridge, UK, to support the manufacture of retinal pigment epithelium (RPE) cells to be used in a cell therapy clinical trial.